AAP
RXST icon

Arax Advisory Partners’s RxSight RXST Stock Holding History

Arax Advisory Partners’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.1K Buy
2,281
+1,552
+213% +$12.9K ﹤0.01% 2269
2025
Q4 		$7.6K Sell
729
-2,456
-77% -$24.6K ﹤0.01% 2624
2025
Q3 		$28.6K Buy
3,185
+2,924
+1,120% +$25.7K ﹤0.01% 2108
2025
Q2 		$3.39K Buy
261
+236
+944% +$3.55K ﹤0.01% 2376
2025
Q1 		$632 Buy
25
+2
+9% +$59 ﹤0.01% 2485
2024
Q4 		$791 Buy
+23
New +$1.04K ﹤0.01% 2218

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Arax Advisory Partners's RXST Position: Q1 2026 in Review

Arax Advisory Partners increased its RxSight (RXST) stake by 213% in Q1 2026, buying an estimated $12.9K and bringing the position to 2,281 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

Arax Advisory Partners first reported a position in RXST in Q4 2024 and has held it in 6 quarters since. The position peaked at $28.6K in Q3 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Arax Advisory Partners held 2,281 shares of RxSight worth $14.1K as of Q1 2026.
  • Arax Advisory Partners bought 1,552 RxSight shares in Q1 2026, an estimated $12.9K.
  • RxSight made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2269 holding.
  • Arax Advisory Partners first reported a position in RxSight in Q4 2024 and has held it in 6 quarters since.
  • Arax Advisory Partners's RxSight position peaked at $28.6K in Q3 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.